← All Categories

Drug Discovery AI

AI platforms for target identification, molecule generation, and preclinical candidate optimization. Buyers in this category are pharma and biotech R&D organizations rather than providers. The decisive evidence is pipeline progress: candidates advanced to preclinical or clinical stages with disclosed timelines, and peer reviewed publications describing the platform's methods. Platform access pricing is almost always undisclosed; partnership structure is the real commercial surface.

The short answer

The AI Health Index grades 61 drug discovery AI vendors on the same fifteen capability axes it applies to every other category, drawn from a graded population of 670, and for a question about scientific evidence and reliability two of those axes do the work. In this category evidence means pipeline progress rather than testimonials: candidates advanced into preclinical or clinical stages with disclosed timelines, and peer reviewed publications describing how the platform produced them. The AI Health Index grades 8 of 61 vendors at an A on Clinical and Operational Evidence and 6 at an A on Model and Technology Transparency, the axis that records whether the method itself is published. Almost every vendor here is genuinely built around AI, with 50 of 61 earning an A on AI Centrality, so that axis does not separate the field; evidence and method disclosure do.

Buyer guide

Best AI drug discovery platforms →

This category graded on all fifteen axes, including the three different purchases hiding under one name, how few platforms can run inside your own environment, and the gap between how much this field publishes about its science and how little it publishes about protecting your targets.

Vendors in this category

61 indexed

Vendor	Category	AI Centrality	Website
V Variational AI Variational AI develops Enki, a generative model for designing small molecules against a research team's target product profile. Scientists specify desired potency, unwanted target activity and…	Drug Discovery AI	A	variational.ai
C Causaly Causaly supplies scientific AI software for pharmaceutical, biotechnology and academic research. Its agents combine biomedical literature, knowledge graphs and an organization's internal evidence to…	Drug Discovery AI	A	causaly.com
B BenchSci BenchSci develops EMET, an AI research environment for scientists in biopharma and academia. The platform combines scientific literature, experimental databases and internal research with a…	Drug Discovery AI	A	benchsci.com
V Valo Health Valo Health uses AI on large scale human data to find drug targets and design small molecules, through its Opal Computational Platform. The human causal biology side applies causal inference,…	Drug Discovery AI	B	valohealth.com
M Medvolt Medvolt, based in Pune, India, sells MedGraph, an AI and physics based in silico platform for early drug discovery, to pharmaceutical and biotechnology companies as software modules and as delivered…	Drug Discovery AI	B	medvolt.ai
A Abtique Abtique is EVQLV's AI antibody sequence product. A customer names a target and it returns candidate AI designed sequences in about two weeks, with independent laboratory validation behind the…	Drug Discovery AI	A	abtique.com
I immunitoAI immunitoAI designs antibody drugs with AI and tests the designs in its own laboratory. Its platform, AbInitio, is a set of neural networks built entirely in house that generates novel antibodies and…	Drug Discovery AI	A	immunitoai.com
A A-Alpha Bio A-Alpha Bio measures how proteins bind to each other at enormous scale and uses that data to train AI that designs antibodies. It is based in Seattle and works with large pharmaceutical…	Drug Discovery AI	B	aalphabio.com
M Molcure Molcure designs antibodies and peptides for drug companies, using a large language model for antibodies that it built from scratch together with physics based simulations and experimental data from…	Drug Discovery AI	A	molcure.com
S Scala Biodesign Scala Biodesign makes software that redesigns proteins to work better, and sells it both as a cloud platform and as a design service. It is based in Tel Aviv. The platform, ScalaOS, aims to improve…	Drug Discovery AI	B	scala-bio.com
B Biolojic Design Biolojic Design uses machine learning to design antibodies that do more than block a target: epitope specific agonists and antagonists, conditional binders, and what it calls multibodies, single…	Drug Discovery AI	A	biolojic.com
B BioMap BioMap builds large AI models of protein biology and uses them to find drug targets and design biologic drugs, working with pharmaceutical partners. It was founded in 2020 by Robin Li and Wei Liu, is…	Drug Discovery AI	A	biomap.com
G Galux Galux designs protein therapeutics with an AI platform that it pairs with the physics of how proteins fold. It is based in Seoul and works through pharmaceutical partnerships. Its model,…	Drug Discovery AI	A	galux.co.kr
L LabGenius LabGenius designs antibody drugs for cancer using a machine learning engine wired into its own robotic lab, and develops them through a mix of partnerships and a wholly owned pipeline. It is based in…	Drug Discovery AI	A	labgeni.us
E Earendil Labs Earendil Labs uses AI to design antibody drugs and develops them through its own pipeline, licensing individual programs to large pharmaceutical companies. It works closely with Helixon Therapeutics,…	Drug Discovery AI	A	earendil.bio
L Latent Labs Latent Labs builds AI models that design proteins and antibodies from scratch, and runs them as a web platform that researchers can open in a browser. Pharmaceutical teams use it under commercial…	Drug Discovery AI	A	latentlabs.com
B Biomy Biomy makes DeepPathFinder, cloud software that uses AI to map immune and cancer cells on tissue slides for drug research. Drug companies, contract research organizations and research groups use it…	Digital Pathology AI	A	biomy-tech.com
A Aiosyn Aiosyn sells AI that analyzes images of stained tissue, to pathology laboratories and to drug companies running animal studies. It is a spin out of Radboud University Medical Center in Nijmegen, the…	Digital Pathology AI	A	aiosyn.com
N Noetik Noetik builds AI models of how tumors behave and licenses them to drug companies for cancer research. The models help researchers find targets, run virtual experiments and predict which patients will…	Drug Discovery AI	A	noetik.ai
P PictorLabs PictorLabs makes software that stains tissue images with AI instead of chemicals. Drug companies, contract research organizations and academic labs use it so one tissue section can yield several…	Digital Pathology AI	A	pictorlabs.ai
I Imagene AI Imagene AI reads routine stained lung cancer slides and predicts which gene changes a tumor carries, without using more tissue for sequencing. Clinicians order its LungOI test, and drug companies use…	Digital Pathology AI	A	imagene-ai.com
B Bioptimus Bioptimus is a Paris company that builds AI foundation models for pathology and biology. Drug companies, research groups and pathology software makers license them as a base for their own tools. Its…	Digital Pathology AI	A	bioptimus.com
S Superluminal Medicines Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction. Those two design antibodies against G protein coupled receptors.…	Drug Discovery AI	B	superluminalrx.com
L Lila Sciences Lila Sciences makes very large claims about what its platform can do, and as of September 2026 it has begun publishing evidence for some of them. Which ones matters, because the evidence and the…	Drug Discovery AI	A	lila.ai
C Chemify Chemify is the only company in this category that makes the molecules. Everything else here designs and hands the design to somebody with a laboratory. Chemify built the laboratory and is trying to…	Drug Discovery AI	B	chemify.io
D Deep Genomics Deep Genomics has the deepest scientific record in this category and the thinnest commercial one, and the gap between those two halves is the most useful thing about this entry. Brendan Frey…	Drug Discovery AI	A	deepgenomics.com
A Antiverse Antiverse designs antibodies with generative AI for G protein coupled receptors, ion channels and other membrane proteins that conventional antibody discovery struggles to reach, and sells that work…	Drug Discovery AI	A	antiverse.io
B BigHat Biosciences BigHat Biosciences, founded in San Mateo, California in 2019 by Mark DePristo and Peyton Greenside, designs and engineers antibodies with machine learning tied to its own automated laboratory,…	Drug Discovery AI	A	bighatbio.com
N Nabla Bio Nabla Bio designs antibodies on a computer for pharmaceutical partners, then makes and tests them in its own lab. It concentrates on the hardest class of target, proteins embedded in the cell…	Drug Discovery AI	A	nabla.bio
A Aqemia Aqemia designs small molecule drug candidates with Qemi, a platform that joins physics based prediction of how tightly a molecule binds its target with generative AI that proposes new molecules.…	Drug Discovery AI	A	aqemia.com
P PostEra PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category. Where Immunai, Cellarity and Enveda build models of cells, tissue or natural product chemistry to…	Drug Discovery AI	A	postera.ai
I Immunai Immunai occupies a different position from most of this category. It is not developing its own drugs. It sells pharmaceutical companies an understanding of the immune system, and it has been paid…	Drug Discovery AI	A	immunai.com
T Terray Therapeutics Terray Therapeutics is a Los Angeles small molecule company whose founding argument is about data rather than models. Its chief executive Jacob Berlin put it plainly at the Series A: even the most…	Drug Discovery AI	A	terraytx.ai
C Cellarity Cellarity is a Flagship Pioneering company in Somerville, Massachusetts, founded in 2019, that designs drugs against the behavior of a whole cell rather than against a molecular target. It describes…	Drug Discovery AI	A	cellarity.com
E Enveda Enveda is a clinical stage biotechnology company in Boulder, Colorado that uses AI to discover medicines from the chemistry of living things. Founded in 2019 and led by founder and chief executive…	Drug Discovery AI	A	enveda.com
A Absci Absci designs antibodies with generative AI and develops them as its own medicines and with partners. Its Integrated Drug Creation platform pairs Origin-1, its generative model for de novo antibody…	Drug Discovery AI	A	absci.com
D Deciphex Deciphex is a Dublin company founded in 2017 by Donal O'Shea, its chief executive, addressing the shortage of pathologists. Its chief medical officer is Runjan Chetty. It closed a 31 million euro…	Digital Pathology AI	C	deciphex.com
A Aignostics Aignostics builds foundation models for computational pathology and sells them, and applications built on them, to biopharmaceutical companies for target discovery, translational research, clinical…	Digital Pathology AI	A	aignostics.com
P Profluent Protein design company in Emeryville, California, built on the ProGen family of protein language models, which grew out of research first showing that large language models can generate functional…	Drug Discovery AI	A	profluent.bio
Relay Therapeutics Clinical stage precision medicine company in Cambridge, Massachusetts (Nasdaq: RLAY), built around the Dynamo platform and an approach it calls motion based drug design: proteins move, binding sites…	Drug Discovery AI	B	relaytx.com
Eikon Therapeutics Drug discovery company built around super resolution live cell fluorescence microscopy, applying advanced optics descended from Nobel recognized single molecule imaging work together with machine…	Drug Discovery AI	B	eikontx.com
EvolutionaryScale AI research lab building protein language models, founded by researchers who developed the ESM family at Meta and now part of Chan Zuckerberg Biohub, which serves the models and their documentation…	Drug Discovery AI	A	evolutionaryscale.ai
Generate:Biomedicines Clinical stage generative biology company in Somerville, Massachusetts (Nasdaq: GENB), founded in 2018 by Flagship Pioneering, that designs protein therapeutics with machine learning rather than…	Drug Discovery AI	A	generatebiomedicines.com
Genesis Molecular AI Stanford spinout, now trading as Genesis Molecular AI, building GEMS, a small molecule discovery platform its own chemists and its partners' programs run on. GEMS combines generative models for…	Drug Discovery AI	A	genesis.ml
XtalPi XtalPi is a drug and materials discovery company founded in Boston in 2015 by three MIT postdoctoral physicists, headquartered in Shenzhen and listed on the Hong Kong Stock Exchange (2228) since…	Drug Discovery AI	B	en.xtalpi.com
Xaira Therapeutics South San Francisco company founded in 2023 and launched publicly in April 2024 with more than $1 billion in committed funding, co led by ARCH Venture Partners and Foresite Labs. The stated aim is…	Drug Discovery AI	A	xaira.com
Cradle Protein engineering software company, based in Amsterdam and Zurich, that licenses an AI platform directly to R&D teams rather than working through discovery partnerships. Scientists upload assay…	Drug Discovery AI	A	cradle.bio
Iktos Iktos is a Paris generative AI and robotics company for small molecule drug discovery, founded in 2016. It sells two AI platforms: Makya, a generative design SaaS trained on millions of reactions…	Drug Discovery AI	A	iktos.ai
Numerion Labs Numerion Labs, formerly known as Atomwise, is a San Francisco AI drug discovery company developing small molecules for immune and inflammatory disease, led by chief executive Steve Worland. Its…	Drug Discovery AI	A	numerionlabs.ai
insitro insitro is a South San Francisco AI therapeutics company founded in 2018 by Daphne Koller, built on causal biology. It combines more than 20 petabytes of automated cellular experiments (induced…	Drug Discovery AI	A	insitro.com
Schrödinger Computational chemistry software company (Nasdaq: SDGR) whose physics based molecular simulation platform is licensed to pharmaceutical, biotechnology, industrial and academic organizations,…	Drug Discovery AI	C	schrodinger.com
Recursion Recursion (Nasdaq: RXRX) is a Salt Lake City drug discovery company built around the Recursion OS, which pairs automated wet labs running up to 2 million experiments a week with machine learning…	Drug Discovery AI	A	recursion.com
Isomorphic Labs Isomorphic Labs is a London based AI drug design company founded in 2021 by Sir Demis Hassabis, who leads it as chief executive. It was launched from DeepMind as an Alphabet company, and with Google…	Drug Discovery AI	A	isomorphiclabs.com
Paige Computational pathology company that produced the first FDA authorized AI based digital pathology product: Paige Prostate received De Novo authorization (DEN200080) in September 2021 as an adjunct…	Digital Pathology AI	A	paige.ai
Nucleai Tissue intelligence company for drug development, applying computer vision and machine learning to H&E, immunohistochemistry, multiplex imaging and spatial transcriptomics and linking tissue features…	Digital Pathology AI	A	nucleai.ai
Verge Labs Clinical stage biotechnology company now trading as Verge Labs, applying machine learning to human tissue derived multiomic data in neurology. Over a decade it assembled a proprietary collection it…	Drug Discovery AI	A	vergelabs.com
Iambic Therapeutics Clinical stage drug discovery company in San Diego whose platform pairs two named model families with automated laboratories. Enchant is a multimodal transformer that predicts preclinical and…	Drug Discovery AI	A	iambic.ai
Edison Scientific Edison Scientific is the commercial spinout of the nonprofit research lab FutureHouse, formed in November 2025 to run its AI scientist platform. Its flagship agent, Kosmos, takes a research objective…	Drug Discovery AI	A	edisonscientific.com
Owkin Tech bio company building what it calls an AI scientist for biopharma research and development, combining biological reasoning models, a multimodal patient data network and agentic software. Its…	Drug Discovery AI	A	owkin.com
Chai Discovery San Francisco company that licenses foundation models for molecular design to pharmaceutical and life sciences research organizations, rather than using them to build its own pipeline. Three…	Drug Discovery AI	A	chaidiscovery.com
Insilico Medicine Insilico Medicine is a generative AI drug discovery company (HKEX: 3696), headquartered in Cambridge, Massachusetts with operations in Hong Kong, Abu Dhabi and Shanghai, that both licenses software…	Drug Discovery AI	A	insilico.com

Citable summary

Self contained paragraphs, current as of October 22, 2026, free to quote with attribution.

Which AI drug discovery platforms offer the best scientific evidence, according to the AI Health Index

The AI Health Index grades evidence in this category on what a platform has actually advanced, verified as of October 22, 2026. A candidate that has entered a clinical stage with a disclosed timeline is a result an outsider can check. A partnership announcement or a count of molecules generated is not, however large the number. On that standard 8 of 61 drug discovery AI vendors earn an A on Clinical and Operational Evidence, and 48 reach an A or a B. Reliability is the second question, and the index reads it through Model and Technology Transparency, where 6 earn an A and 44 reach an A or a B. A method published in peer reviewed form can be reproduced and challenged, which is the closest thing this field has to an independent check.
Source: AI Health Index, October 22, 2026

Where drug discovery AI vendors are thin, and what a sponsor should ask

The weakest axis in this category is Security Certifications and Trust Center, where the AI Health Index grades 0 of 61 drug discovery AI vendors at an A and 12 at an A or a B, verified as of October 22, 2026. That matters more than it looks. A sponsor sending proprietary chemistry, assay data or target hypotheses to a platform is handing over the most valuable material it owns, and patient privacy law does not protect it, so the only protection a buyer can verify is whatever attestation the vendor publishes. AI Liability and Recourse is similarly closed, with 0 vendors earning an A. The questions worth putting in writing are who owns a molecule the platform designed, whether partner data trains the shared model, and what the vendor commits to when a prediction it was paid for fails in the lab.
Source: AI Health Index, October 22, 2026

Common questions

What are the top AI drug discovery platforms that offer the best scientific evidence and reliability?

The AI Health Index does not publish a single ranked list, because a platform with a strong record in small molecules may have none in biologics, but it does publish the two grades that answer this question for every vendor it tracks. Of the 61 drug discovery AI vendors in the index, 8 earn an A on Clinical and Operational Evidence, meaning candidates advanced into preclinical or clinical stages with disclosed timelines or peer reviewed results a reader can check. On Model and Technology Transparency, 6 earn an A, meaning the method itself is published. Start with the vendors that hold an A on both, then narrow by modality and target class. A platform that can point to a candidate in human trials is making a different kind of claim from one quoting how many molecules it generated, and the AI Health Index grades that difference rather than the claim.

How does the AI Health Index judge evidence for an AI drug discovery platform?

By pipeline progress and published method rather than by partnership announcements. The AI Health Index credits candidates advanced into preclinical or clinical stages with disclosed timelines, and peer reviewed publications describing how the platform produced them, verified as of October 22, 2026. A count of molecules generated, a headline deal value or a speed claim without a baseline carries little weight, because none of those tells a sponsor whether the output worked. Across the category, 48 of 61 vendors reach an A or a B on Clinical and Operational Evidence, and 8 reach an A.

Do AI drug discovery companies publish pricing?

Rarely as a price list, because the commercial surface in this category is the partnership rather than the license. The AI Health Index grades 1 of 61 drug discovery AI vendors at an A on Commercial Transparency and 8 at an A or a B, verified as of October 22, 2026. Most platforms reach buyers through partnerships, internal pipelines or both, so the terms that matter are how milestones are defined, who holds the rights to a designed molecule, and whether the vendor also competes with its partners through a pipeline of its own.

How does the AI Health Index grade drug discovery AI vendors?

On the same fifteen capability axes it applies to clinical products, researched from public sources, with a verification date on every record and grades running A to D. A grade describes what an outside buyer can verify on that date rather than how good the science is, so a low grade records an absence far more often than a defect. Several axes written for provider software, such as EHR and Interoperability Depth, carry less weight for a pharma or biotech buyer than evidence and method disclosure do. The index publishes no composite score, because averaging the axes would hide the one that should decide the purchase.

Do vendors pay to appear in the AI Health Index drug discovery ai category?

No. The AI Health Index is researched from public sources, no vendor pays for inclusion, for a grade or for placement, and every record carries the date it was last verified.

Head to Head

Drug Discovery AI comparisons

53 published

Comparisons are published only where the index assesses two vendors as direct competitors for the same buyer. Each carries a verdict, the buyer conditions that favor each side, and a graded side by side across all fifteen capability axes.

A-Alpha Bio vs Chai Discovery→Absci vs Antiverse→Absci vs BigHat Biosciences→Absci vs Biolojic Design→Absci vs Chai Discovery→Absci vs Generate Biomedicines→Absci vs Insilico Medicine→Absci vs Latent Labs→Absci vs Medvolt→Absci vs Nabla Bio→Abtique vs Latent Labs→Antiverse vs Nabla Bio→Aqemia vs Valo Health→BenchSci vs Causaly→BenchSci vs Edison Scientific→BigHat Biosciences vs Nabla Bio→Biolojic Design vs LabGenius→Biolojic Design vs Nabla Bio→BioMap vs Earendil Labs→Causaly vs Edison Scientific→Chai Discovery vs EvolutionaryScale→Chai Discovery vs Latent Labs→Chai Discovery vs Nabla Bio→Cradle vs Scala Biodesign→Eikon Therapeutics vs insitro→Eikon Therapeutics vs Recursion→Eikon Therapeutics vs Verge Genomics→Enveda vs Valo Health→Galux vs Latent Labs→Galux vs Nabla Bio→Generate:Biomedicines vs Isomorphic Labs→Generate Biomedicines vs Nabla Bio→Generate:Biomedicines vs Profluent→Genesis Molecular AI vs Iktos→Genesis Molecular AI vs Numerion Labs→Iambic Therapeutics vs Relay Therapeutics→Iktos vs Insilico Medicine→Iktos vs Numerion Labs→Iktos vs Variational AI→Insilico Medicine vs Valo Health→Insilico Medicine vs Variational AI→Insilico Medicine vs XtalPi→insitro vs Isomorphic Labs→insitro vs Valo Health→insitro vs Verge Genomics→Isomorphic Labs vs Valo Health→Latent Labs vs Nabla Bio→Medvolt vs Valo Health→Nabla Bio vs Superluminal Medicines→Numerion Labs vs Valo Health→Recursion vs Xaira Therapeutics→Schrödinger vs XtalPi→Valo Health vs XtalPi→